Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre- and post-liver transplantation patients.

ER, Schiff; CL, Lai; S, Hadziyannis; P, Neuhaus; N, Terrault; M, Colombo; HL, Tillmann; D, Samuel; S, Zeuzem; L, Lilly; M, Rendina; JP, Villeneuve; N, Lama; C, James; MS, Wulfsohn; H, Namini; C, Westland; S, Xiong; GS, Choy; Doren S, Van; J, Fry; CL, Brosgart

doi:10.1016/j.hep.2003.09.040

Public

Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre- and post-liver transplantation patients.

Shared by NobleBlocks on Dec 1, 2003 • 12:00 AM UTC

Authors:

Schiff ER

Lai CL

Hadziyannis S

Abstract

Three-hundred and twenty-four patients were enrolled in an open-label, multicenter, international study in which pre- and post-liver transplantation (LT) patients with recurrent chronic hepatitis B (CHB) and evidence of lamivudine-resistant HBV were treated with adefovir dipivoxil 10 mg once daily. ...

Discussions